MIAMI, May 10, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced its participation in Vitafoods Europe 2024, scheduled to take place in Geneva, Switzerland from May 14 to 16, 2024.
Vitafoods Europe is a premier event in the nutraceutical industry, typically attracting over 25,000 industry experts, and is renowned for its spotlight on the latest advancements and trends shaping the future of health and wellness. Smart for Life’s presence at Vitafoods Europe signifies a meaningful opportunity for the company to explore strategic partnerships and potential acquisitions, further cementing its position as a pivotal player in the sector.
As part of the event, Smart for Life’s recently appointed board member, Heather Granato, a renowned nutraceutical industry member and the president of Women In Nutraceuticals, will be a speaker at Vitafoods Europe on Thursday, May 16. She will join a panel of industry experts sharing valuable perspectives on the evolving landscape for women’s health products in the nutraceutical industry, and the role of women in leadership and science to driving innovation and growth.
“With an unwavering commitment to driving innovation and excellence in the nutraceutical landscape, Smart for Life aims to establish partnerships that not only enhance our product offerings but also deliver substantial value to consumers and stakeholders alike,” stated Darren Minton, CEO of Smart for Life. “We are pleased that Heather Granato has been selected as a speaker at Vitafoods Europe 2024, and we believe our participation at the event underscores our steadfast dedication to fostering positive transformation within the nutraceutical industry. We look forward to engaging with industry leaders and exploring potential opportunities that drive engagement and collaboration.”
Companies interested in scheduling meetings with Smart for Life during Vitafoods Europe are encouraged to reach out directly to arrange appointments.
For media inquiries or to schedule interviews with Smart for Life representatives, please contact: media@smartforlifecorp.com.
About Vitafoods Europe
Vitafoods Europe attracts over 25,000 industry experts from over 130 countries, offering fantastic opportunities for networking, collaboration and innovation in the nutraceutical industry. Operating since 1997, the trade show hosts live editions annually in Geneva at Palexpo. It offers the perfect platform for businesses to thrive and forge long term collaborations, enrich their understanding and initiate critical conversations around the most pressing issues concerning the health and nutrition industry. To learn more, please visit: www.vitafoods.eu.com
About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on Health & Wellness. Structured as a publicly held holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company recently concluded the execution of a restructuring plan including recapitalization of the Company with equity and debt financings, the sale of certain non-performing assets, the sale and leaseback of the Company’s 18,000 sq. ft. Doral manufacturing facility and the successful liquidation of the Company’s senior debt facility. In addition, the Company converted substantial debt obligations to equity materially improving the Company’s balance sheet. The Company has signed a definitive agreement for the acquisition of Purely Optimal Nutrition, which is expected to add additional revenue and EBITDA. For more information about Smart for Life, please visit: www.smartforlifecorp.com.
Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.
Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.
Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com
